Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON52981
NL-OMON52981
Completed
Not Applicable

MEDIASTINAL STAGING OF NON SMALL CELL LUNG CANCER BY ENDOBRONCHIAL AND ENDOSCOPIC ULTRASONOGRAPHY WITH OR WITHOUT ADDITIONAL SURGICAL MEDIASTINOSCOPY (MEDIASTrial) - MEDIASTrial

Maxima Medisch Centrum0 sites356 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Maxima Medisch Centrum
Enrollment
356
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
April 1, 2023
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Maxima Medisch Centrum

Eligibility Criteria

Inclusion Criteria

  • •Patients with (suspected) NSCLC without distant metastases and suspected
  • •metastatic nodal spread on PET or CT scan; or a non PET\-avid or centrally
  • •located tumour or a peripheral tumour \>3 centimeters diameter. Previous
  • •EBUS/EUS has shown negative biopsy results.

Exclusion Criteria

  • •Not eligible are patients with: a) highly suspected bulky mediastinal nodal
  • •disease; b) high suspicion of single level N2\-3 metastasis defined by specific
  • •PET and EBUS/EUS characteristics; c) suspected non\-resectable N2 disease; d)
  • •insufficient comprehension of the dutch language.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
ong-term treatment for cancer patients with deep vein thrombosis or pulmonary embolism - a randomized open label study1002765510014523venous thrombosis / clot
NL-OMON39493Academisch Medisch Centrum10
Completed
Not Applicable
Selecting cancer patients for treatment using Tumor Organoids, the SENSOR study
NL-OMON46891ederlands Kanker Instituut61
Completed
Phase 2
Mesenchymal stromal cells for treatment of drug resistant pediatric Juvenile idiopathic arthritisjuvenile idiopathic arthritis1000381610023213
NL-OMON39754niversitair Medisch Centrum Utrecht6
Completed
Phase 3
Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer - Cachexia (NSCLC-C): An Extension Study;(ROMANA-3)cachexiewasting syndroom1000301810027656
NL-OMON38190Helsinn Therapeutics (U.S.), Inc1
Completed
Phase 3
Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer - Cachexia (NSCLC-C): A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study to Evaluate the Safety and Efficacy of Anamorelin HCl in Patients with NSCLC-Ccachexiawasting syndroom1000301810027656
NL-OMON37977Helsinn Therapeutics (U.S.), Inc2